These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. [Studies on the toxicity of amikacin (BB-K8),III. Subacute toxicity of amikacin (BB-K8) in dogs (author's transl)]. Matsuzaki M; Akutsu S; Yoshida A; Onodera K; Sekino M Jpn J Antibiot; 1975 Aug; 28(4):458-84. PubMed ID: 1160143 [No Abstract] [Full Text] [Related]
29. [Effect of minocycline (Minomycin) granules on infectious impetigo, and influence of combination with Enteronon-R on intestinal canal (author's transl)]. Minami H; Noda T; Yoshinari M; Nakao I; Ueda Y Jpn J Antibiot; 1974 Oct; 27(5):664-70. PubMed ID: 4455959 [No Abstract] [Full Text] [Related]
30. Therapy of impetigo and furunculosis. Fritsch WC JAMA; 1970 Dec; 214(10):1862-6. PubMed ID: 5537340 [No Abstract] [Full Text] [Related]
31. [Basic and clinical evaluation on clindamycin palmitate in otorhinolaryngological field infection (author's transl)]. Iwasawa T Jpn J Antibiot; 1973 Aug; 26(4):393-9. PubMed ID: 4542676 [No Abstract] [Full Text] [Related]
32. [Clinical results with amikacin (BB-K8) in respiratory infections (author's transl)]. Ito T Jpn J Antibiot; 1976 Aug; 29(8):731-4. PubMed ID: 957522 [No Abstract] [Full Text] [Related]
33. [Evaluation of ototoxicity of amikacin (BB-K8) by animal test (author's transl)]. Akiyoshi M; Sato K; Nakada H; Tajima T; Suzuki K Jpn J Antibiot; 1975 Jun; 28(3):288-304. PubMed ID: 1152283 [TBL] [Abstract][Full Text] [Related]
34. [Ototoxic effect of BB-K8 administered to pregnant guinea pigs on development of inner ear of intrauterine litters (author's transl)]. Akiyoshi M; Yano S; Tajima T; Matsuzaki M; Akutsu S Jpn J Antibiot; 1977 Feb; 30(2):185-96. PubMed ID: 857059 [TBL] [Abstract][Full Text] [Related]
35. [Fundamental and clinical studies on amikacin (BB-K8) in complicated urinary tract infections (author's transl)]. Mita T; Mayumi K; Kataoka N; Ishigami J Jpn J Antibiot; 1977 Mar; 30(3):215-22. PubMed ID: 404447 [No Abstract] [Full Text] [Related]
36. [Comparison of absorption and excretion of powdery preparation for injection and liquid preparation of BB-K8 (amikacin) (author's transl)]. Okubo H; Okamoto Y; Uba F; Ueda Y; Ueda T Jpn J Antibiot; 1975 Jun; 28(3):283-7. PubMed ID: 1152282 [No Abstract] [Full Text] [Related]
37. [Clinical use of acetylspiramycin in dermatology]. Tachibana K; Yamaha M; Takeda T J Antibiot B; 1966 Dec; 19(6):441-3. PubMed ID: 5298391 [No Abstract] [Full Text] [Related]
38. [Comparison of the antibacterial activity of amikacin (BB-K8) with other aminoglycosides against pathogens recently isolated from clinical materials (author's transl) ]. Kosakai N; Oguri T Jpn J Antibiot; 1975 Aug; 28(4):530-7. PubMed ID: 240047 [TBL] [Abstract][Full Text] [Related]
39. [Teratological studies of amikacin (BB-K8) in rabbit (author's transl)]. Matsuzaki M; Akutsu S; Mukogawa H; Aizawa T Jpn J Antibiot; 1975 Jun; 28(3):366-71. PubMed ID: 1152290 [No Abstract] [Full Text] [Related]